期刊文献+

HPLC-MS/MS法测定C6胶质瘤荷瘤大鼠脑组织中替尼泊苷的浓度 被引量:2

Determination of Teniposide in C6 Glioma Tumor-Bearing Rat Brain Tissue by Sensitive Liquid Chromatography/Tandem Mass Spectrometry
原文传递
导出
摘要 目的建立测定C6胶质瘤荷瘤大鼠脑组织中替尼泊苷含量的高效液相色谱-串联质谱联用法。方法脑组织匀浆后用乙酸乙酯-二氯甲烷(4∶1)液-液提取,流动相重组离心后进样分析。色谱柱为LichrospherC18(2.1mm×100mm,5μm)柱,依托泊苷为内标,以甲醇-0.1%甲酸的5mmol·L-1乙酸铵(70∶30)为流动相,流速0.2mL.min-1,柱温35℃,以多反应离子监测方式检测:替尼泊苷[M+NH4]+,m/z674/383;内标:依托泊苷[M+NH4]+,606/229。结果替尼泊苷和内标依托泊苷的保留时间分别在2.7和2.2min,替尼泊苷的线性范围为3~300μg·L-1。提取回收率大于75%,方法回收率大于90%,日内、日间RSD<10%(n=5)。结论本试验方法简便快速,适用于替尼泊苷体液的浓度测定,利于新药临床研究。 OBJECTIVE To establish a rapid HPLC-MS/MS method for the determination of teniposide concentration in C6 glioma tumor-bearing rat brain tissue. METHODS The samples were extracted from homogenated brain tissue with ethyl acetate-dichlormethane(4 : 1) by twice liquid-liquid extraction, and the sample was injected after reconstitution with mobile phase . Chromatograph was carried out on a Lichrospher C18 (2.1 minx 100 mm, 5 pm) column, using etoposide as internal standard, and the concentrations of teniposide were determined. The mobile phase was methyl alcohol-0.5 mmol·L^-1 ammonium acetate (contain 0.1% formic acid) (70 : 30). The flow rate was set at 0.2 mL·min^-1. Column temperature was 35 ℃ and the samples were analyzed by mass spectrometry in the multitude reaction ion monitoring mode using the target [M+NH4]^+ ions m/z 674/383 for teniposide and 606/229 for internal standard etoposide. RESULTS The retention times of teniposide and etopside were 2.7 and 2.2 min, respectively. A good linearity was shown in the range of 3-300 μg·L^-1. The extraction recovery was over 75% and the method recovery was over 90%. The interday or intraday precisions were less than 10% in replicate analysis (n=5). CONCLUSION This HPLC-MS/MS method is simple, quick. It is suitable for the determination of teniposide humoral concentration, and clinical investigation.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第15期1173-1176,共4页 Chinese Pharmaceutical Journal
基金 南京市医学科技发展课题(YKK05066)
关键词 替尼泊苷 依托泊苷 质谱法 高压液相 脑组织浓度 teniposide: etoposide mass spectrometry high pressure liquid brain tissue concentration
  • 相关文献

参考文献4

二级参考文献18

  • 1王先祥,冯春国,李长元.人脑胶质瘤肿瘤标志物研究现状[J].安徽医学,2004,25(6):506-508. 被引量:1
  • 2赵澎,张亚卓.鼠胶质瘤动物模型的建立及应用[J].国外医学(神经病学.神经外科学分册),2005,32(1):38-41. 被引量:6
  • 3林健,王伟民,徐如祥,姜晓丹.9L/Fischer344与C6/Wistar两种大鼠脑胶质瘤模型的比较研究[J].中华神经医学杂志,2005,4(5):445-448. 被引量:4
  • 4[1]Loikle JD,Brewer CF,Sternlight H,et al.Structure-activity study of the inhibition of microtubule assembley in vitro by podophyllotoxim and its congeners[J].Cancer Res,1978,38:2688.
  • 5[2]Bossa R,Galatulas I,Leotta L,et al.Effects of various antitumor drugs on aneragetic processes[J].Pharmacol Res Commun,1976,8(4):369.
  • 6[3]Brouty-Boye G,Constans JP.In vitro comparative action of some chemotherapeutic agents on cell lines originating from human brain tumors[J].Neurochirurgie 1976,22(1):69.
  • 7吴苏澄,姜云平,钟义,邵文军.高效液相色谱法测定替尼泊甙注射液含量[J].华西药学杂志,1997,12(2):117-118. 被引量:1
  • 8石远凯,中国新药杂志,1994年,3卷,4期,7页
  • 9You Y.Podophyllotoxin derivatives:current synthetic approaches for new anticancer agents[J].Curr Pharm Design,2005,11(13):1695.
  • 10Gordaliza M,Castro MA,del Corral JM,et al.Antitumor properties of podophyllotoxin and related compounds[J].Curr Pharm Des,2000,6(18):1811.

共引文献10

同被引文献16

  • 1杨正明,王明盛,陈坚.In vitro Study of Interstitial Combination Chemotherapy in the Treatment of Glioma[J].The Chinese-German Journal of Clinical Oncology,2005,4(6):378-380. 被引量:3
  • 2牟英迪,林振广,刘宜辉.抗肿瘤药物替尼泊苷[J].齐鲁药事,2007,26(5):315-315. 被引量:7
  • 3UMEMURA K,YANASE K, SUZUKI M,et al. Inhibition of DNA topoisomerases I and II, and growth inhibition of human cancer cell lines by a marine microalgal polysaccharide [ J ]. Biochem Pharmacol,2003,66 ( 3 ) :481-487.
  • 4ZHANG Y, GUPTA A, WANG H, et al. BCRP Transports dipyridamole and is inhibited by calcium channel blockers [ J ]. Pharm Res, 2005,22(12): 2023-2034.
  • 5DAITJ.Quantitative analysis of drug combination .中国药理学通报,1998,14(5):479-480.
  • 6LU C, SHERVINGTON A. Chemoresistance in gliomas[ J]. Mol Cell Biochem, 2008, 312(1-2):71-80.
  • 7ROGER B, SANDRINE V W, ALAIN P. Cancer stem cells: the emerging challenge of drug targeting [ J ]. Curr Med Chem, 2009, 16(4) :394-416.
  • 8DAOOD M, TSAI C, AHDAB-BARMADA M,et al. ABC Transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS [ J ]. Neuropediatrics, 2008, 39(4) :211-218.
  • 9SHUKLA S, ROBEY R W, BATES S E, et al. The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2 [ J ]. Biochemistry, 2006,45 ( 29 ) : 8940 -8951.
  • 10XIAO F Z, XIN N Y, QI W,et al. Effects of dihydropyridines and pyridines on multidrug resistance mediated by breast cancer resistance protein: in vitro and in vivo studies [ J ]. Drug Metab Dispos ,2005 ,33 ( 8 ) : 1220-1228.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部